Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07116109
- Status
- Recruiting
Conditions
- Chronic Pain
- Post Traumatic Stress Disorder (PTSD)
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Direct Current Stimulation (tDCS) — DEVICEA constant current intensity of 2 Ma electrical current will be administered for 20 min per session/ 10 sessions total daily for 2 weeks (Monday to Friday)using the headgear M1-SO montage placement.
- Massed-Prolonged Exposure (PE) — BEHAVIORALPE will include a) psychoeducation about the common reactions to traumatic events and presentation of the treatment rationale (sessions 1 and 2), b) repeated in vivo exposure to traumatic stimuli (in vivo exercises are assigned as homework during sessions 3 through 10), c) repeated, prolonged, imaginal exposure to traumatic memories (sessions 3 through 10). All sessions will be delivered via telehealth.
- Sham Transcranial Direct Current Stimulation (tDCS) — DEVICESham tDCS delivers an active stimulation of 2 Ma electrical current) for a few seconds to mimic the sensations of active tDCS
Study Details
The purpose of this study is to examine comparative effectiveness of two home-based telemedicine delivered interventions: transcranial Direct Current Stimulation (tDCS) combined with Massed Prolonged Exposure (Massed-PE) vs. Sham tDCS combined with Massed PE, focusing on pain and PTSD outcomes, to determine the comparative effectiveness of the two interventions on process outcomes of patient satisfaction, treatment attrition, and treatment compliance and to explore changes in blood biomarkers associated with stress and inflammatory processes related to pain and PTSD symptom improvements following treatment.
Key Dates
- Start date
- Jul 1, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 146 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Transcranial Direct Current Stimulation (tDCS) and Massed-Prolonged Exposure (PE)
- Sham Comparator: Sham Transcranial Direct Current Stimulation (tDCS) and Massed-Prolonged Exposure (PE)
Primary Outcome Measure
Change in pain intensity as measured by the Defense and Veterans Pain Rating Scale (DVPRS) [ Time Frame: Baseline, midpoint(before session 6), post treatment (after session 10) 3 months, 6 months ]
Central Contacts
- Melba Hernandez-Tejada, PhD, DHA713 4862729
- Stephanie Hart843-577-5011 x205103
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Charleston VA Healthcare System | Charleston | South Carolina | 29401-5799 | |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | - |
Find similar trials in Charleston, SC
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona
- A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain ManagementEARLY_PHASE1 · Not Yet Recruiting · HillMed Inc. · Houston, Texas
- Novel Cellular Therapy for the Treatment of Pain Associated With Chronic PancreatitisPHASE1 · Recruiting · VA Office of Research and Development · Charleston, South Carolina